Meyka Pro banner
Bruker Corporation

Bruker Corporation (BRKR) Stock Overview

Explore Bruker Corporation’s financial performance, market position, analyst ratings, and future outlook.

BRKR●NASDAQ
HealthcareMedical - Devices
$66.54
$5.23(8.53%)
U.S. Market opens in 15h 50m

Bruker Corporation (BRKR)

Meyka AI Score

Z

Key Financials

Market Cap10.1B
P/E Ratio-55.44
EPS (TTM)$1.99
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$67.13
3 Months$78.67
1 Year Target$47.86

BRKR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Bruker Corporation (NASDAQ: BRKR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bruker Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BRKR on the NASDAQ shows an RSI of 60.99, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $47.86 for the NASDAQ listing.

Key metrics behind Bruker Corporation's NASDAQ-traded stock include a P/E ratio of -55.44 and a market capitalization of 10.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BRKR on the NASDAQ.

Price Performance (NASDAQ: BRKR)

1-Day Change
8.53%
5-Day Change
1.76%
1-Month Change
13.09%
3-Month Change
24.58%
6-Month Change
50.68%
Year-to-Date (YTD) Change
41.24%
1-Year Change
63.17%
3-Year Change
16.25%
5-Year Change
-19.58%
All-Time (Max) Change
188.55%

Contact Information

978 663 3660
40 Manning Road, Billerica, MA, 01821

Company Facts

110,850 Employees
IPO DateAug 4, 2000
CountryUS
Actively Trading

Frequently Asked Questions